The receptor internalization and degradation (RID) complex of adenovirus plays an important role in modulating the immune response by downregulating the surface levels of tumour necrosis factor receptor 1 (TNFR1), thereby inhibiting NF-kB activation. Total cellular content of TNFR1 is also reduced in the presence of RID, which can be inhibited by treatment with lysosomotropic agents. In this report, surface biotinylation experiments revealed that, although RID and TNFR1 were able to form a complex on the cell surface, the rate of TNFR1 endocytosis was not affected by RID. However, the degradation of internalized TNFR1 was enhanced significantly in the presence of RID. Therefore, these data suggest that RID downregulates TNFR1 levels by altering the fate of internalized TNFR1 that becomes associated with RID at the plasma membrane, probably by promoting its sorting into endosomal/lysosomal degradation compartments.
The successful replication and survival of viruses in the host requires evasion of the immune system. Many of the immunomodulatory genes of adenovirus (Ad) are encoded in early region 3 (E3) (Fessler et al., 2004b; Horwitz, 2004) . The E3 receptor internalization and degradation (RID) complex, composed of two RIDa and one RIDb subunits, downregulates a specific set of plasma-membrane receptors, including FAS (Shisler et al., 1997; Elsing & Burgert, 1998; Tollefson et al., 1998) , tumour necrosis factor (TNF)-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) (Benedict et al., 2001; Tollefson et al., 2001 ) and epidermal growth factor receptor (EGFR) (Carlin et al., 1989; Tollefson et al., 1991) . Together with another E3 protein, E3/6.7K, RID also reduces the surface expression of TRAIL-R2 (Lichtenstein et al., 2004) . Whilst both of the RID subunits are critical for the downregulation of FAS and TRAIL receptors, it appears that the RIDa subunit is sufficient to downregulate EGFR under certain experimental conditions (Hoffman et al., 1990) . Recently, we demonstrated that RID also downregulates TNFR1, thereby inhibiting TNF-induced NF-kB activation, which mediates the transcription of a large number of genes involved in inflammation and immune responses such as chemokine expression (Fessler et al., 2004a; Delgado-Lopez & Horwitz, 2006) .
In vivo experiments have shown that RID is an essential component of the Ad E3 cassette, which facilitates transplantation of allogeneic pancreatic cells (Efrat et al., 1995) and decreases autoimmune type 1 diabetes incidence (von Herrath et al., 1997; Efrat et al., 2001; Pierce et al., 2003) . To potentially use RID as a therapeutic immunomodulator, it is important to elucidate the molecular mechanism of RIDmediated downregulation of receptors. We recently showed that the tyrosine sorting motifs of RIDb and clathrin play important roles in the downregulation of TNFR1, and that RID-mediated TNFR1 degradation occurs via an endosomal/ lysosomal pathway (Chin & Horwitz, 2005) . In this report, we further examined the effect of RID on TNFR1 trafficking. Specifically, we tested the ability of RID to interact with TNFR1 on the cell surface and investigated whether RID enhances TNFR1 endocyotosis, or rather promotes the degradation of internalized TNFR1.
We have shown previously that mutation in the tyrosine sorting motif of RIDb [ 122 tyrosine (Y) mutated to phenylalanine (F); RIDb(YF)] not only abolishes the downregulation of surface TNFR1, but paradoxically increases surface TNFR1 expression, suggesting that RID and TNFR1 may form a complex on the cell surface (Chin & Horwitz, 2005) . To investigate this directly, cell-surface biotinylation was performed followed by co-immunoprecipitation and NeutrAvidin pull-down (Fig. 1a) . HeLa cells were infected with a total m.o.i. of 5000 particles per cell (1 p.f.u. is equivalent to 20 virus particles) of Ad vectors (Chin & Horwitz, 2005) , is the corresponding negative control with no ORF in the E1 region of Ad. Fourteen hours post-infection, cells were surface-biotinylated and whole-cell lysates were prepared. RID-interacting proteins were recovered by anti-RIDb immunoprecipitation. Following elution from the antibody, biotinylated proteins were precipitated with immobilized NeutrAvidin. Proteins precipitated by NeutrAvidin beads (cell-surface proteins), as well as proteins that could not be precipitated by NeutrAvidin (intracellular proteins), were analysed by Western blotting with rabbit anti-RIDb antiserum, mouse anti-TNFR1 antibody and anti-transferrin receptor antibody. (b) Results are representative of three independent experiments performed as described in (a). The multiple bands of RIDb were fully consistent with different post-translational modifications of RIDb (Tollefson et al., 1990) , including phosphorylation and O-glycosylation . Interestingly, the higher-and lower-molecular-mass species of RIDb were found on the cell surface and intracellularly, respectively. To our knowledge, these are the first observations to suggest that certain post-translational modifications allow the trafficking of RIDb to the cell surface. Nevertheless, our results showed that both high-and low-molecular-mass RIDb were able to interact with TNFR1. NIgG, Non-immune rabbit IgG; WB, Western blotting; co-IP, co-immunoprecipitation. ml 21 (Pierce) in PBS for 30 min at 4 u C. The biotinylation reaction was quenched by rinsing cells three times with Tris-buffered saline. Whole-cell lysates were prepared and co-immunoprecipitation was performed by using a Seize primary mammalian immunoprecipitation kit (Pierce) , where affinity-purified rabbit anti-RIDb antibody (Genemed Synthesis Inc.; Chin & Horwitz, 2005) or non-immune rabbit IgG (Santa Cruz Biotechnology) was cross-linked to immobilized protein G before immunoprecipitation. The immunoprecipitated complex was eluted in an acidic elution buffer and the eluant was neutralized by adding 2?5 ml 1 M Tris (pH 9?5) per 50 ml of sample. The immunoprecipitated complex was then dissociated in 1 % SDS by heating at 95 u C for 7 min and then diluted 20-fold with lysis buffer [1 % Triton X-100, 150 mM NaCl, 1 mM EDTA, 2 mM Na 2 P 2 O 7 , 30 mM NaF, 20 mM Tris/HCl (pH 7?5) and 16 complete proteinase inhibitor cocktail (Roche Molecular Biochemicals)]. Biotinylated proteins were then precipitated with 30 ml immobilized NeutrAvidin (Pierce) for 2 h at 4 u C. The beads were washed four times with lysis buffer and once with PBS. Proteins precipitated by NeutrAvidin beads were analysed by Western blotting Fig. 1(b) ], suggesting that RID and TNFR1 are able to interact on the cell surface, either directly or through an intermediate bridging molecule. On the other hand, transferrin receptor, which was shown previously not to be downregulated by RID (Carlin et al., 1989; Tollefson et al., 1998) , did not co-immunoprecipitate with RIDb, thus providing a specificity control for the Western blot. RIDb(YF), which itself has a higher level of surface expression, co-immunoprecipitated more plasma-membrane TNFR1 than did wild-type (WT) RIDb [left panel of Fig. 1(b) ]. These results agree with previous observations that the tyrosine sorting motif of RIDb plays an important role in determining surface levels of RID (Hilgendorf et al., 2003) and TNFR1 (Chin & Horwitz, 2005) . Interestingly, although there was less RIDb(YF) mutant present intracellularly than WT RIDb, similar amounts of intracellular TNFR1 were co-immunoprecipitated [middle panel of Fig. 1(b) ]. It is possible that TNFR1, or the molecule that mediates the interaction between TNFR1 and RID, has a higher affinity for the RIDb(YF) mutant than the WT RIDb. Taken together, although we cannot completely rule out the possibility that part of the surface TNFR1 signal may be derived from internal labelling, the increased signal detected for RIDb(YF) supports the view that labelling indeed occurred at the cell surface. Therefore, these data suggest that RID is able to associate with TNFR1 on the cell surface. It is also noteworthy that, although TNFR1 appears to interact with RID on the cell surface, the interaction is much more pronounced in the intracellular fraction.
We next investigated whether RID downregulates surface TNFR1 by enhancing its endocytosis rate, or rather by promoting degradation of internalized TNFR1. In order to find the most appropriate time to carry out the assays, we first performed a kinetic study of RID-mediated TNFR1 downregulation. 293 cells (5610 5 ) were infected with 1000 particles Ad/null per cell for 13 h or 1000 particles Ad/RID per cell for various durations (0-13 h). Downregulation of surface TNFR1 by RID was then assayed by flow cytometry as described previously (Chin & Horwitz, 2005) . As shown in Fig. 2(a) , the maximal TNFR1 downregulation activity by RID was between 5 and 7 h post-infection (the steepest slope of the curve). Therefore, the endocytosis assay was performed at 5?5 h post-infection, when RID had a significant activity towards downregulation of surface TNFR1, yet sufficient amounts of surface TNFR1 were still present to enable accurate quantification.
Cleavable biotin was used in the surface biotinylation assay to measure TNFR1 endocytosis. 293 cells were infected with 1000 particles Ad/null or Ad/RID per cell for 5?5 h. To label cell-surface proteins, cells were washed three times with ice-cold PBS with 0?1 mM CaCl 2 and 1 mM MgCl 2 (PBS-CM), followed by incubation with 480 mg cleavable EZ-link Sulfo-NHS-SS-biotin ml 21 (Pierce) for 30 min at 4 u C. Unreacted biotin was quenched by rinsing once with 50 mM glycine in PBS-CM and twice with PBS-CM. Recombinant human TNF (100 ng ml 21 ; R&D Systems) was added to the indicated samples. Cells were then incubated at 4 uC to block internalization or at 37 uC for 4 or 6 min to allow endocytosis to occur. Cells were rinsed twice with ice-cold PBS-CM/10 % fetal bovine serum (FBS). The remaining surface biotin was cleaved by incubating with glutathione cleavage buffer (50 mM reduced glutathione in 75 mM NaCl, 75 mM NaOH, 10 % FBS) twice for 20 min at 4 uC, whereas the internalized biotinylated proteins were protected from the cleavage. Cells were washed with Dulbecco's modified Eagle's medium (DMEM; Cellgro) and then incubated with PBS-CM with 1 % FBS and 1 mg iodoacetamide ml 21 for 15 min at 4 uC. Cells were lysed and biotinylated proteins were precipitated with NeutrAvidin. Samples were subjected to Western blotting and protein levels were quantified by using Scion Image software. Fig. 2(b) shows that the kinetics of TNFR1 endocytosis were very similar in Ad/null-and Ad/RID-infected cells, with approximately 10 and 20 % of surface TNFR1 internalized in 4 and 6 min, respectively (Fig. 2c) . TNFR1 endocytosis was also examined up to 15 min incubation at 37 uC, with no difference observed between Ad/null-and Ad/RID-infected cells (data not shown). RID was detectable on the cell surface as well as being endocytosed (Fig. 2b) , suggesting that the lack of an effect in TNFR1 internalization rate was not due to the lack of RID expression. To control for potential leakage of biotin across the plasma membrane, the amount of biotinylated b-tubulin was quantified on the same blot. The abundant intracellular protein b-tubulin was not biotinylated (Fig. 2b) , suggesting that only cell-surface proteins were biotinylated and cell integrity was maintained during biotinylation. For comparison, cells were also stimulated with TNF, which has been shown to induce TNFR1 internalization (Higuchi & Aggarwal, 1994; Porteu & Hieblot, 1994) . As expected, TNFR1 endocytosis was increased significantly in the presence of TNF (Fig. 2b) . These results are in accord with the notion that TNFR1 internalizes continuously (Yoshie et al., 1986) . Importantly, the data showed that RID did not downregulate TNFR1 by increasing its endocyotsis rate. Therefore, we hypothesized that RID downregulates surface TNFR1 by altering the fate of internalized TNFR1.
We have shown previously that RID decreases the total levels of TNFR1, which can be reversed by inhibitors of endosomal acidification (Chin & Horwitz, 2005) . However, these studies assessed total cellular TNFR1 levels. In order to focus specifically on the fate of internalized TNFR1 and determine whether its degradation was enhanced in the presence of RID, a modified surface biotinylation assay was used. 293 cells were infected with 1000 particles Ad/null or Ad/RID per cell. At 4 h post-infection, when RID had no effect on the cell-surface level of TNFR1 (Fig. 2a) , cells were rinsed twice with ice-cold PBS. Surface proteins were biotinylated with 300 mg EZ-link Sulfo-NHS-biotin ml 21 (Pierce) as described in the legend to Fig. 1 . Cells were then lysed immediately to determine the initial amount of surface TNFR1 or incubated in DMEM supplemented with 2 % FBS for various times (2, 3 or 4 h) at 37 uC to allow trafficking and degradation of biotinylated TNFR1. NeutrAvidin precipitation was then performed to recover biotinylated TNFR1 remaining on and inside the cells. Detection of biotinylated TNFR1 and transferrin receptor on the Western blot was done as described above.
As shown in Fig. 3(a) , there were similar amounts of biotinylated TNFR1 in Ad/null-and Ad/RID-infected cells at 4 h post-infection. After incubating cells at 37 uC for 2-4 h, there was less biotinylated TNFR1 recovered from the Ad/RID-infected cells than from the Ad/null-infected cells at all time points examined, indicating that internalized TNFR1 was degraded more rapidly in the presence of RID. By fitting a second-order polynomial curve to the data, the half-life of degradation of surface TNFR1 in Ad/nullinfected cells was approximately 99 min, whereas in the presence of RID, the half-life of TNFR1 was shortened to 63 min (Fig. 3b) . For comparison, the amount of transferrin receptor was also quantified on the same blot (Fig. 3a) . Biotinylated transferrin receptors exhibited little or no degradation at all time points examined, agreeing with previous observations that, once being internalized, transferrin receptors were recycled back to the plasma membrane instead of being degraded in lysosomes (Mayor et al., 1993) . The constant levels of biotinylated transferrin receptor also control for the possible non-specific effects of viral infection on cell viability and function. In addition, the lack of effect on transferrin receptor by RID suggests that the effect of RID on TNFR1 degradation was specific. As a control, biotinylation of the intracellular protein b-tubulin was not observed (data not shown), confirming that no biotin leaked across the plasma membrane during the biotinylation procedure. These results indicated that RID enhanced the degradation of internalized TNFR1.
As TNF is a proinflammatory cytokine that modulates viral pathogenesis (reviewed by Herbein & O'Brien, 2000) , a number of viral proteins target the TNF receptor and components of its associated signalling pathways. In this study, we have demonstrated that RID downregulates the surface levels of TNFR1 without accelerating its rate of endocytosis. To our knowledge, this is the first report showing that a viral protein promotes the degradation of endocytosed TNFR1. The mechanisms by which RID enhances TNFR1 degradation remain to be elucidated. It is possible that, by associating with TNFR1 on the cell surface, RID stimulates mono-ubiquitination of TNFR1 or causes the exposure of a cryptic degradation or sorting signal on TNFR1, thereby rerouting the recycling TNFR1 to the endosomal/lysosomal pathway. Interestingly, RID also downregulates EGFR by enhancing its degradation, without affecting its endocytosis rate (Hoffman & Carlin, 1994) ; this agrees with the finding that RIDa associates with EGFR in early endosomes (Crooks et al., 2000) . For TNFR1, we showed here that RID could associate with TNFR1 on the cell surface. In addition, downregulation of TNFR1 by RID is decreased in the presence of small interfering RNAs against the m2 subunit of AP-2, a complex that plays an important role in clathrinmediated endocytosis (Chin & Horwitz, 2005) . However, RID has no effect on the TNFR1 endocytosis rate. These data suggested that, instead of accelerating the internalization of TNFR1, RID and clathrin play an important role in mediating delivery of TNFR1 to intracellular sites that accelerate its degradation, probably late endosomes or lysosomes, as lysosomotropic agents prevent degradation of TNFR1 by RID (Chin & Horwitz, 2005) .
Experiments in this study did not address whether RID was degraded together with TNFR1 in the lysosomes. However, previous observations showed limited co-localization of RIDb and FAS in lysosomes (Hilgendorf et al., 2003) . In addition, whereas EGFR was degraded in lysosomes, RIDa was retained on the limiting membrane of multivesicular bodies (Crooks et al., 2000) . Thus, it is possible that RID escapes to the recycling pathway for another round of internalization. Indeed, it would be advantageous for the virus to use the same protein repeatedly for enhancing the efficiency of receptor downregulation.
Although experiments of the current study were performed with CMV promoter-driven RID, previous flow-cytometry experiments from our laboratory have shown that infection of 293 cells with WT adenovirus led to a modest (~17 %) downregulation of TNFR1 (data not shown), suggesting that TNFR1 downregulation by RID is not restricted to an artificial system. We believe that our current mechanistic studies with the potentially overexpressed CMV promoterdriven RID are relevant for natural adenovirus infection, as expression levels and effects of RID in vivo are likely to be dependent on the cell type, as well as many other parameters. Nonetheless, the potential of expressing and utilizing E3 proteins, including RID, out of the context of adenovirus to facilitate allogeneic cell transplantation and decrease the incidence of type I autoimmune diabetes prompts further studies aimed at dissecting precise mechanisms of RID-mediated TNFR1 degradation.
